Header Logo

Connection

Ana Laus to Drug Resistance, Neoplasm

This is a "connection" page, showing publications Ana Laus has written about Drug Resistance, Neoplasm.
Connection Strength

0.098
  1. Raquel-Cunha A, Pinheiro J, Marques RF, Font?o P, Cardoso-Carneiro D, Mendes A, Gomes INF, Laus AC, da Silva-Oliveira RJ, Reis RM, Martinho O. RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR-targeted therapies. Mol Oncol. 2025 Nov; 19(11):3205-3222.
    View in: PubMed
    Score: 0.054
  2. Lengert AVH, Pereira LDNB, Cabral ERM, Gomes INF, Jesus LM, Gon?alves MFS, Rocha AOD, Tassinari TA, Silva LSD, Laus AC, Vidal DO, Pinto MT, Reis RM, Lopes LF. Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors. Front Biosci (Landmark Ed). 2022 08 16; 27(8):245.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.